The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This is a single-center, randomized, open-label, placebo-controlled, dose-escalation trial. The objective of this research is to evaluate the safety, tolerability, and efficacy of intrathecal administration of human-induced neural stem cell-derived extracellular vesicles (NouvSoma001) for the treatment of neuromyelitis optica spectrum disorders.
Epistemonikos ID: e5cd15c8943b031b20e7d4018f0a959fbc1e8c6b
First added on: Apr 17, 2025